142 related articles for article (PubMed ID: 30612854)
1. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.
Brown ES; Sayed N; Choi C; Tustison N; Roberts J; Yassa MA; Van Enkevort E; Nakamura A; Ivleva EI; Sunderajan P; Khan DA; Vazquez M; McEwen B; Kulikova A; Frol AB; Holmes T
Eur Neuropsychopharmacol; 2019 Mar; 29(3):376-383. PubMed ID: 30612854
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.
Brown ES; Wolfshohl J; Shad MU; Vazquez M; Osuji IJ
Neuropsychopharmacology; 2008 Sep; 33(10):2376-83. PubMed ID: 18004283
[TBL] [Abstract][Full Text] [Related]
3. Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.
Brown ES; Zaidel L; Allen G; McColl R; Vazquez M; Ringe WK
J Affect Disord; 2010 Nov; 126(3):415-9. PubMed ID: 20580827
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy.
Desai S; Khanani S; Shad MU; Brown ES
J Clin Psychopharmacol; 2009 Jun; 29(3):284-7. PubMed ID: 19440084
[TBL] [Abstract][Full Text] [Related]
5. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy.
Brown ES; Stuard G; Liggin JD; Hukovic N; Frol A; Dhanani N; Khan DA; Jeffress J; Larkin GL; McEwen BS; Rosenblatt R; Mageto Y; Hanczyc M; Cullum CM
Biol Psychiatry; 2005 Mar; 57(5):543-8. PubMed ID: 15737670
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.
Brown ES; Lu H; Denniston D; Uh J; Thomas BP; Carmody TJ; Auchus RJ; Diaz-Arrastia R; Tamminga C
J Affect Disord; 2013 Sep; 150(2):551-8. PubMed ID: 23453674
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of an NMDA receptor antagonist for reversing corticosteroid effects on the human hippocampus.
Brown ES; Kulikova A; Van Enkevort E; Nakamura A; Ivleva EI; Tustison NJ; Roberts J; Yassa MA; Choi C; Frol A; Khan DA; Vazquez M; Holmes T; Malone K
Neuropsychopharmacology; 2019 Dec; 44(13):2263-2267. PubMed ID: 31181564
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy.
Brown ES; Vazquez M; Nakamura A
Biol Psychiatry; 2008 Oct; 64(8):727-729. PubMed ID: 18582848
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.
Brown ES; J Woolston D; Frol A; Bobadilla L; Khan DA; Hanczyc M; Rush AJ; Fleckenstein J; Babcock E; Cullum CM
Biol Psychiatry; 2004 Mar; 55(5):538-45. PubMed ID: 15023583
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts.
Brown ES; Denniston D; Gabrielson B; Khan DA; Khanani S; Desai S
Allergy Asthma Proc; 2010; 31(4):331-6. PubMed ID: 20819324
[TBL] [Abstract][Full Text] [Related]
11. Effect of two prednisone exposures on mood and declarative memory.
Brown ES; Beard L; Frol AB; Rush AJ
Neurobiol Learn Mem; 2006 Jul; 86(1):28-34. PubMed ID: 16458545
[TBL] [Abstract][Full Text] [Related]
12. Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment.
Gurler D; White DM; Kraguljac NV; Ver Hoef L; Martin C; Tennant B; Lahti AC
Neuropsychobiology; 2021; 80(1):12-24. PubMed ID: 32316023
[TBL] [Abstract][Full Text] [Related]
13. Amygdala volume in patients receiving chronic corticosteroid therapy.
Brown ES; Woolston DJ; Frol AB
Biol Psychiatry; 2008 Apr; 63(7):705-9. PubMed ID: 17981265
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol modulation of hippocampal glutamate in early psychosis.
O'Neill A; Annibale L; Blest-Hopley G; Wilson R; Giampietro V; Bhattacharyya S
J Psychopharmacol; 2021 Jul; 35(7):814-822. PubMed ID: 33860709
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone.
Brown ES; Jeon-Slaughter H; Lu H; Jamadar R; Issac S; Shad M; Denniston D; Tamminga C; Nakamura A; Thomas BP
Neuropsychopharmacology; 2015 Mar; 40(5):1216-21. PubMed ID: 25409592
[TBL] [Abstract][Full Text] [Related]
16. Impact of levetiracetam on mood and cognition during prednisone therapy.
Brown ES; Frol AB; Khan DA; Larkin GL; Bret ME
Eur Psychiatry; 2007 Oct; 22(7):448-52. PubMed ID: 17766093
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy.
Brown ES
Ann N Y Acad Sci; 2009 Oct; 1179():41-55. PubMed ID: 19906231
[TBL] [Abstract][Full Text] [Related]
19. 3T hippocampal glutamate-glutamine complex reflects verbal memory decline in aging.
Nikolova S; Stark SM; Stark CEL
Neurobiol Aging; 2017 Jun; 54():103-111. PubMed ID: 28363111
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
Kraguljac NV; Morgan CJ; Reid MA; White DM; Jindal RD; Sivaraman S; Martinak BK; Lahti AC
Schizophr Res; 2019 Aug; 210():239-244. PubMed ID: 30630705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
